患者和类风湿病学家对利图西马布在类风湿性关节炎中的剂量减少的看法
Delphine Bertrand1, Anke Deprez1,2, Michaël Doumen1,3
1Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium.
Musculoskeletal care
|May 2, 2024
概括
患者和类风湿病学家认为,降低类风湿性关节炎 (RA) 治疗的利图西马布剂量有好处,理由是安全性和成本节省. 然而,人们对有效性和生活质量的担忧仍然存在,这凸显了共享决策的必要性.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
- 患者为中心的护理
背景情况:
- 治疗类风湿性关节炎 (RA) 的标准利图西马布剂量包括两次1000毫克输液.
- 新出现的证据表明,较低的Rituximab剂量可能同样有效.
- 调查患者和风湿病学家对利图西马布剂量降低的看法至关重要.
研究的目的:
- 为了探索患者和风湿病学家关于在RA治疗中减少rituximab剂量的看法.
- 为了确定与较低的Rituximab剂量相关的感知益处和担忧.
主要方法:
- 使用半结构面试与RA患者和类风湿病学家进行的定性研究.
- 用于确保参与者多样性的有目的抽样.
- 有根据的理论和数据分析的常数比较方法.
主要成果:
- 患者和风湿病学家将安全性和降低社会成本确定为剂量降低的关键好处.
- 感知到的优势包括支持较低剂量和个性化治疗量身定制的证据.
- 人们担心潜在的有效性丧失,生活质量下降以及风湿病学家的经验有限.
结论:
- 患者和类风湿病学家都认为,减少rituximab剂量有好处,包括提高安全性,成本效益和个性化护理.
- 尽管对疗效存在担忧,但大多数患者和风湿病学家都愿意考虑剂量降低策略.
- 共享决策和明确的医生沟通对于实施个性化的rituximab剂量至关重要.
相关概念视频
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160
01:01Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
134
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
134
01:15Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K